Search for: "Janssen Research " Results 61 - 80 of 202
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Aug 2015, 10:38 am by Dr. Shezad Malik
Xarelto is made by Bayer and Janssen Pharmaceuticals, and is the second to be released and has rapidly gained the lion share of the market. [read post]
11 Nov 2016, 10:29 am by Law Offices of Jeffrey S. Glassman
As it turns out, one type of machine used to monitor a patient’s blood was defective and was not providing researchers with accurate test results. [read post]
18 Apr 2011, 5:51 pm by FDABlog HPM
Linda, who will primarily assist HP&M’s drug development group, brings significant experience and expertise in shaping regulatory policies, particularly Comparative Effectiveness Research, Personalized Medicine, and Evidence-Based Medicine.  [read post]
14 Feb 2010, 4:20 pm by Aaron Barkoff
The utility requirement also prevents the patenting of a mere research proposal or an invention that is simply an object of research.”  [read post]
29 Jan 2018, 5:00 am by melissalafreniere
Janssen Research & Development, Case No. 2:17-cv-17835, in the U.S. [read post]
24 Mar 2015, 11:54 am by Dr. Shezad Malik
Most recently, a wrongful death lawsuit was filed against the makers of Xarelto; Bayer Healthcare and Johnson and Johnson’s subsidiary, Janssen. [read post]
23 Nov 2015, 8:00 am by Robert Kreisman
Janssen Pharmaceuticals Inc., Johnson & Johnson Company and Johnson Pharmaceutical Research and Development, LLC, No. 130401990, Philadelphia County, Court of Common Pleas (Nov. 11, 2015). [read post]
28 Feb 2014, 9:27 pm by Legal Reader
(Hereinafter “Janssen”); (2) Johnson & Johnson; (3) Johnson & Johnson Pharmaceutical Research & Development, L.L.C; (4) Excerpta Medica Inc.; and (5) Elsevier Inc. [read post]
10 Sep 2019, 5:00 am by Dani Alexis Ryskamp
Andrew Kolodny, the co-director of the Opioid Policy Research Collaborative at Brandeis University, stated that Johnson & Johnson had played a role in the creation of three different types of opioids: natural, semi-synthetic, and synthetic. [read post]
24 Oct 2017, 12:30 pm by Tom Lamb
Future Clinical Trials And Investigations Need To Clarify Whether This Amputation Drug Injury Could Be A Class Effect Of All SGLT2 Inhibitors   (Posted by Tom Lamb at   During this year we have written several times about the still developing drug safety issue of lower limb amputations linked to Invokana use:  A "Dear Doctor" Letter For Invokana Amputations Side Effect Was Sent September 2017 By Janssen In Canada Analysis Of FDA Adverse Event… [read post]
30 Dec 2015, 9:10 pm
" Contents include:Vincent Bernard, Time to take prevention seriously Interview with Emanuele Castano - Professor and Chair of Psychology, New School for Social Research Knut Dörmann & Jose Serralvo, Common Article 1 to the Geneva Conventions and the obligation to prevent international humanitarian law violations Naz K. [read post]
9 Jul 2014, 9:05 pm by FDABlog HPM
District Court for the Southern District of New York against The Kennedy Trust for Rheumatology Research, which holds third-party patents – here, here, and here – that allegedly cover infliximab.) [read post]
25 Jan 2016, 6:44 am by Law Offices of Jeffrey S. Glassman
First, it should be noted that researchers at Janssen Pharmaceuticals, which is a wholly owned subsidiary of giant drug manufacturer Johnson & Johnson, conducted this study. [read post]
29 Dec 2017, 5:00 am by melissalafreniere
Janssen and Johnson & Johnson made billions off the drug and it is still prescribed currently. [read post]
5 Jan 2018, 5:00 am by melissalafreniere
Johnson and Johnson’s Janssen Pharmaceuticals and Bayer Health Care market Xarelto and together they shared the news of the failed phase three study in a press release last October. [read post]
29 Dec 2016, 8:26 am by Clay Hodges
Despite large amounts of time and money spent on drug and medical device research and development, those drugs and devices don’t always work as intended. [read post]